a public good project by the
Synthesis
Company
of California

© 2026

Min Gao | doi.page

0 works0 citations0 h-index

Min Gao

Oregon Health & Science University(US)Jilin University(CN)First Hospital of Jilin University(CN)

Publications by Year

Research Areas

Hepatitis C virus research, Nanoplatforms for cancer theranostics, HIV/AIDS drug development and treatment, Nanoparticle-Based Drug Delivery, Cancer-related molecular mechanisms research

Most-Cited Works

→ Erythrocyte‐Membrane‐Enveloped Perfluorocarbon as Nanoscale Artificial Red Blood Cells to Relieve Tumor Hypoxia and Enhance Cancer Radiotherapy(2017)590 cited
→ Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion(2020)536 cited
→ Synthesis of Hollow Biomineralized CaCO₃–Polydopamine Nanoparticles for Multimodal Imaging-Guided Cancer Photodynamic Therapy with Reduced Skin Photosensitivity(2018)491 cited
→ Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity(2021)398 cited
→ Degradable Molybdenum Oxide Nanosheets with Rapid Clearance and Efficient Tumor Homing Capabilities as a Therapeutic Nanoplatform(2015)297 cited
→ Polydopamine Nanoparticles as a Versatile Molecular Loading Platform to Enable Imaging-guided Cancer Combination Therapy(2016)289 cited

→ CaCO3 nanoparticles as an ultra-sensitive tumor-pH-responsive nanoplatform enabling real-time drug release monitoring and cancer combination therapy(2016)278 cited

→ Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon System(2010)272 cited

→ Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy(2021)238 cited

→ IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases(2024)228 cited